Skip to content

Category: Medical Health Aged Care

ANANDA Scientific and the David Geffen School of Medicine, UCLA, Announce Commencement of a Clinical Trial Evaluating Nantheia(TM) ATL5 for Smoking Cessation

By API User

GREENWOOD VILLAGE, Colo. & LOS ANGELES–BUSINESS WIRE– ANANDA Scientific Inc., a research focused bio-pharmaceutical company, and the Semel Institute for Neuroscience at Geffen School of Medicine UCLA today announced the commencement of aclinical trial evaluating Nantheia™ ATL5, an investigational drug combining cannabidiol (CBD) with ANANDA’s proprietary delivery technology, to evaluate the efficacy of cannabidiol for … Continued

NDIS reform brings clarity for people at the end of life

By API User

People living with disabilities at the end of life now have more clarity around who provides the care and supports central to their quality of life. “Over the last 12 to 24 months, we’ve been hearing from our members and other voices in the sector that people under 65 with disabilities linked to a life-limiting … Continued

Queensland’s healthcare system remains strong amid rapidly growing population and challenges

By API User

A new report by The McKell Institute Queensland has revealed the state’s health system has remained resilient and continues to perform at or above national averages across several critical metrics, despite unprecedented population growth and rising healthcare demands. The report, titled A Healthy Queensland: A snapshot of the Queensland health sector, highlights the strength of … Continued

BeiGene Receives Positive CHMP Opinions for TEVIMBRA® as a First-Line Treatment for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer and Esophageal Squamous Cell Carcinoma

By API User

Positive opinion for first-line treatment of gastric or gastroesophageal junction cancer based on results of RATIONALE-305 study demonstrating statistically significant overall survival benefit for TEVIMBRAin combination with platinum- and fluoropyrimidine-based chemotherapy Positive opinion for first-line treatment of esophageal squamous cell carcinoma based on results of RATIONALE-306 study demonstrating statistically significant overall survival benefit for TEVIMBRA … Continued

RACGP welcomes Tasmanian health minister Jacquie Petrusma

By API User

The Royal Australian College of GPs (RACGP) has welcomed new Minister for Health in Tasmania Jacquie Petrusma MP and praised outgoing Minister for Health Guy Barnett. Mr Barnett will take on the role of Treasurer alongside his Attorney-General and Minister for Justice portfolios. Ms Petrusma, who was a registered nurse before being elected to state … Continued

ASDS 2024: New Phase III READY-4 Data Demonstrate Long-Term Safety and Efficacy of Galderma’s RelabotulinumtoxinA (Relfydess(TM))

By API User

First results from the phase III READY-4 trial demonstrate the long-term safety of repeated injections of RelabotulinumtoxinA for both frown lines and crow’s feet, with efficacy and patient satisfaction maintained across multiple treatments1 These results were presented alongside additional data from the phase III READY clinical trial program showing RelabotulinumtoxinA’s long duration of effect for … Continued

Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset

By API User

The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases Cureverse receives undisclosed upfront payments and is eligible for future milestone-dependent payments and royalties, while retaining rights to commercialize CV-01 in the Republic of … Continued